-+ 0.00%
-+ 0.00%
-+ 0.00%

IMMUNITYBIO INC - PRELIMINARY Q1 2026 NET PRODUCT REVENUE $44.2 MLN, UP 168% YEAR-OVER-YEAR

Reuters·04/09/2026 11:32:24

Please log in to view news